Close Menu

NEW YORK – Chinese diagnostic company WuXi Diagnostics announced on Tuesday that it has closed a $150 million Series B financing round.

The round was led by new investors including Thermo Fisher Scientific, Shiyu Capital, ABC International, Sunland Capital, and CCBI Tech Venture, Existing investor YF Capital, along with CEC Capital, were the exclusive financial advisor.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.